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keeping the above restraints. Then 800 ps simulations at 310 K were carried out. Third, equilibration was performed in the NpT ensemble with a constant pressure of 1 atm controlled using Langevin Piston method and at constant temperature of 310 K regulated by Langevin dynamics. During equilibration the restraints have been gradually decreased: a scaling factor on the force constant for heavy atoms of group 1 and 2 has been decreased from 1 to 0.025 for 3 ns in 10 time windows. Additionally, 1 ns MD was carried out with the 0.025 scaling factor.
Further, in the production runs, the constraints on heavy atoms of group 2 were completely released while those imposed on atoms of the border group 1 were preserved but scaled by a factor of 0.01. This was to assure that the boundary atoms taken out from the ribosome structure still "feel" the ribosome environment. Group 1 and 2 residues and restraints are schematically shown in Figure S1 .
The protocol for free aminoglycosides was similar as above but no restraints were applied in the production phase. Periodic boundary conditions and Particle Mesh Ewald method with grid spacing of 1 Å were used. The SHAKE algorithm 11 and the integration time step of 2 fs were applied. For nonbonded interactions a short-range cutoff of 12 Å was used.
The production runs of 500 ns were performed three times for free solute and in the complexes with compounds 2, 4, 8, 9 and of 250 ns for free aminoglycosides, each run started with different velocities.
The classical MD production simulations totaled to 3.5s. Root mean square deviation (RMSD) analyses confirmed the stability of the solute in classical MD simulations (see Figure S2 ). Figure S2 . RMSD from the starting structure calculated for the heavy atoms of the solutes (RNA and
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protein fragments but excluding solvent and ions) as a function of the simulation time in three independent classical MD simulations of the free solute and in the complexes with different compounds marked in the legend.
Random Acceleration Molecular Dynamics (RAMD) Simulations
To assess kinetic stability of aminoglycosides within the A site, we used random acceleration molecular dynamics (RAMD) 12 . In RAMD, constant force in a random direction is applied to the aminoglycoside to more extensively sample the conformational space and dissociate aminoglycoside from its binding site. The starting structures for RAMD were taken from classical MD production trajectories. Additional force was a randomly generated normalized vector multiplied by an acceleration factor of 35 kcal/mol/Å. The force was imposed on the oxygen atom of the linkage between aminoglycoside ring I and II because this atom is the closest to the center of mass of aminoglycoside non-hydrogen atoms (see Figure 1 in the main text). Every 100 steps, the distance from the starting position of this oxygen to the current one and the distance travelled by this oxygen were calculated. If aminoglycoside oxygen travelled at least 0.0002 Å in 100 steps and the distance from the starting point was larger than in the previous evaluation, the simulation continued with the same force direction. Otherwise, a new random force vector was generated. We assumed that aminoglycoside escaped A site when the distance of the above oxygen atom from the initial position was at least 10 Å.
However, if aminoglycoside did not escape for at least 50 ns, we stopped RAMD simulation. For 4 aminoglycoside complexes and 3 starting structures from classical MD production runs, 30 RAMD runs were performed totaling to 360 RAMD simulations and about 6.6s.
Trajectory analysis
MD trajectories were analyzed with cpptraj of AmberTools16. VMD 1.9.3 13 was used for visualization. Plots were generated with xmgrace and Gnuplot (v4.6). To detect short-range interactions, we used the geometric criteria of 3.2 Å between the donor and acceptor atoms and no less than 150 degrees donor-hydrogen-acceptor angle. To extract dominant conformations clustering analysis on combined trajectories was performed with the kmeans algorithm. The optimal number of clusters (between 2 to 5) was identified by trial and error. The quality of clustering was evaluated by comparing DBI (Davies-Bouldin Index), which is a measure of the separation of clusters, and pSF (pseudo-F statistic), which estimates the tightness of clusters. The lower the DBI and the higher pSF the better. and copper (II) sulfate (6 mg, 0.24 mmol) were dissolved in water (5.0 mL). Triflic azide stock solution prepared from Tf2O (4.6 mL, 27.6 mmol) and NaN3 (3.6 g, 55.7 mmol) was added followed by the addition of methanol (40 mL) to reach the homogeneous solution. The reaction mixture (blue color)
was stirred vigorously at room temperature and the completion of the reaction was indicated by the change of blue color to green. After stirring for 48 h, TLC (EtOAc/MeOH 95:5) analysis finally indicated the completion of the reaction. The solvents were evaporated to dryness and the residue was subjected to column chromatography (EtOAc 100%) to yield compound 12 (650 mg, 52 %). 1 3.94 (dd, 1H, J = 10.2, 9.1 Hz, H-3), 3.84 (dd, 1H, J = 11.9, 2.3 Hz, H-6), 3.78 (dd, 1H, J = 11.8, 4.4
Hz, H-6), 3.46 (dd, 1H, J = 9.7, 9.3 Hz, H-4), 3.13 (dd, 1H, J = 10.5, 3. 
S10
To a stirred solution of the silyl ether from above step (1.0 g, 1.79 mmol) under argon atmosphere in dry pyridine (15 mL), was added dropwise BzCl (1.5 mL, 12. Compound 14: A stirred solution of compound 13 (1.1 g, 1.12 mmol) under argon in dry pyridine (10 mL) was cooled to 0-4 o C in a polyethylene vessel. At this temperature, the solution of HF in pyridine (5 mL) was added dropwise. The progress of the reaction was monitored by TLC (EtOAc/Hexane 3:7), which indicated completion after 3.5 h. The reaction mixture was diluted with EtOAc and extracted with H2O, NaHCO3 (sat.). The organic layers again washed with HCl (2%), NaHCO3 (sat.), and brine.
The combined organic layer was dried over MgSO4, evaporated to dryness, and purified by column chromatography (silica gel, EtOAc/Hexane) to yield corresponding primary alcohol (0.756 g, 82%). 1 H S11 NMR (600 MHz, CDCl3): 'Ring I': δH 6.0 (dd, 1H, J1 = 10.7, J2 = 9.5 Hz, H-3), 5.39 (d, 1H, J = 3.9
Hz, H-1), 5.34 (dd, 1H, J1 = 10.1, J2 = 9. The primary alcohol product from the previous step (0.1 g, 0.12 mmol) was dissolved in CH2Cl2 74.1 (C6), 73.5 (C5), 70.0 (C4'), 69.9 (C3'), 69.0 (C5'), 60.7 (C2'), 58.5 (C3), 58.2 (C1), 31.8 (C2).
MALDI TOFMS calculated for C40H33N9O12 ([M+Na]
+ ) m/e 854.2146; measured m/e 854.2114). purified by flash chromatography on a short column of silica gel. The column was washed with the following solvents: THF (100 mL), CH2Cl2 (100 mL), EtOH (50 mL), and MeOH (100 mL). The product was then eluted with the mixture of 5% MeNH2 solution (prepared from the 33% stock solution of MeNH2 in EtOH) MeOH. Fractions containing the product were combined and evaporated under vacuum. The pure product was obtained by passing the above product through a short column of Amberlite CG50 (NH4 + form). First, the column was washed with water, then the product was eluted S13 with a mixture of 10% NH4OH in water to yield the acid 6 (150 mg, 67%). For the storage and biological tests, the compound was converted to its sulfate salt form as follow. The free base form was dissolved in water, the pH was adjusted to 7.0 with H2SO4 (0.1 N) and lyophilized to afford the sulfate salt of 6. To a stirred solution of the tetraol amide product from the above step (261 mg, 0.63 mmol) in a mixture of THF (3.0 mL) and aqueous NaOH (1 mM, 5.0 mL), PMe3 (1 M solution in THF, 3.0 mL, 7.8 equiv.) was added. The progress of the reaction was monitored by TLC [CH2Cl2/MeOH/H2O/MeNH2 (33% solution in EtOH), 10:15:6:15], which indicated completion after 3.5 h. The reaction mixture was purified by flash chromatography on a short column of silica gel. The S15 column was washed with the following solvents: THF (100 mL), CH2Cl2 (100 mL), EtOH (50 mL), and MeOH (100 mL). The product was then eluted with the mixture of 5% MeNH2 solution (33% solution in EtOH) in 80% MeOH. Fractions containing the product were combined and evaporated under vacuum. The pure product was obtained by passing the above product through a short column of Amberlite CG50 (NH4 + form). First, the column was washed with water, then the product was eluted with a mixture of 10% NH4OH in water to yield compound 7 (120 mg, 57%). For the storage and biological tests, the compound was converted to its sulfate salt form as follow. The free base form was dissolved in water, the pH was adjusted to 7.0 with H2SO4 (0.1 N) and lyophilized to afford the sulfate salt of 7. Compound 19: Anhydrous CH2Cl2 (20 mL) was added to a powdered, flame-dried 4 Å molecular sieves (2.0 g), followed by the addition of acceptor 16 (874 mg, 1.0 mmol) and donor 17 (2.11 g, 4.01 mmol). The reaction mixture was stirred for 10 min at room temperature and was then cooled to -30°C.
At this temperature, catalytic amount of BF3-Et2O (0.2 mL) was added and the mixture was stirred at -30 °C and the reaction progress was monitored by TLC, which indicated the completion after 60 min.
The reaction mixture was diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The combined organic layer was dried over MgSO4, evaporated and subjected to column chromatography (EtOAc/Hexane) to obtain the titled compound 19. Hz, H-6), 3.52 (dd, 1H, J1 = 10.6, J2 = 4.2 Hz, H-2); 'Ring II': δH 5.28 (t, 1H, J = 9.9 Hz, H-6), 4.11 (t, 1H, J = 9. EtOAc and extracted with H2O, NaHCO3 (sat.). The organic layers again washed with HCl (2%), NaHCO3 (sat.), and brine. The combined organic layer was dried over MgSO4, evaporated to dryness,
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and purified by column chromatography (silica gel, EtOAc/Hexane) to yield corresponding primary alcohol (1.34 g, 67% over 2 steps 
